What researchers published on Psoriatic arthritis
767 papers, newest first.
Showing 40 of 767
Measuring treatment response in psoriatic arthritis: comparison between PSoriatic Arthritis Response Criteria and Disease Activity Score.Rheumatology advances in practice
ReviewEfficacy and safety of deucravacitinib versus placebo in active psoriatic arthritis: a systematic review and meta-analysis.Autoimmunity reviews
Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.)
Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.Rheumatology and therapy
Observational studyUnderstanding barriers: patient experience with immune-mediated rheumatic diseases in Brazilian public health.Advances in rheumatology (London, England)
ReviewMultidomain efficacy and safety of IL-17A and IL-17A/F inhibitors versus adalimumab in biologic-naïve psoriatic arthritis: A systematic review and Meta-analysis of comparative trials.Autoimmunity reviews
Foot and ankle involvement is common across the spondyloarthritis spectrum with distinct anatomical and clinical patterns: a post hoc cross-sectional analysis of the ASAS-PerSpA study.Rheumatology international
Extracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study.Frontiers in immunology
Impact of radiographic damage on health-related outcomes across rheumatoid arthritis, psoriatic arthritis, and hand osteoarthritis: a comparative analysis of disease burden.Clinical rheumatology
Implementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study.Journal of drugs in dermatology : JDD
Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors.Journal of drugs in dermatology : JDD
Bimekizumab in Psoriatic Arthritis: 12-Month Retention, Multidomain Effectiveness, and Impact of Prior Interleukin-17 Inhibition in a Real-World Cohort.Joint bone spine
Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Case reportAdult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review.EULAR rheumatology open
Case reportPsoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.Cureus
Response to correspondence on 'Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials' by Annfeldt et al.Annals of the rheumatic diseases
Difficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry.Seminars in arthritis and rheumatism
The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET).Arthritis & rheumatology (Hoboken, N.J.)
Incidence and prevalence of hidradenitis suppurativa across spondyloarthritis-related diseases: cohort study using electronic health records.Frontiers in immunology
Real‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.Annals of the rheumatic diseases
Simplified liquid chromatography-mass spectrometry quantification of adalimumab reveals peptide interference and modestly stronger exposure-response associations than ELISA.Analytica chimica acta
Predictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA).Rheumatology (Oxford, England)
Meta-analysisEpidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence.Diabetes/metabolism research and reviews
In plain wordsRead moreRead the paper on PubMedImmunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort.Vaccines
Lightweight interpretable support vector machine SERS (LiSVM-SERS) learning framework for serological diagnosis of psoriatic arthritis and biomarker identification.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Systematic reviewExercise, physical activity, and physical fitness in psoriasis and psoriatic arthritis: an umbrella review.Frontiers in immunology
In plain wordsRead moreRead the paper on PubMedIFN-γ, TNF-α, IL-10, IL-17 and IL-22 secretion capacities and activation profile of T cells in psoriatic arthritis patients under disease-modifying antirheumatic drug therapy.Frontiers in immunology
Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis.Lancet regional health. Americas
Prevalence of Psoriatic Arthritis among Patients with Psoriasis Using the Psoriatic Arthritis Screening Tool (PEST) Questionnaire in a Tertiary Government Institution.Acta medica Philippina
Does weather matter? Exploring associations between season and meteorological factors and psoriatic arthritis disease activity.RMD open
C reactive protein in psoriatic arthritis: an old biomarker or a jack of all trades?Rheumatology (Oxford, England)
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double-Blind, Placebo-Controlled APEX Study.Arthritis & rheumatology (Hoboken, N.J.)
Single-cell analysis reveals CXCL16+ dendritic cells and clonally expanded GZMK+ CD4 T cells driving joint inflammation in psoriatic arthritis.Arthritis & rheumatology (Hoboken, N.J.)
Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials.Journal of psoriasis and psoriatic arthritis
Sex-specific outcomes in methotrexate therapy among patients with psoriatic arthritis and psoriasis.EULAR rheumatology open
Observational studyDiagnostic performance of FIB-4 in detecting advanced liver fibrosis in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis using methotrexate.Advances in rheumatology (London, England)
Sex of the Treating Rheumatologist and Disease Activity Outcomes in Psoriatic Arthritis.Mayo Clinic proceedings. Innovations, quality & outcomes
ReviewShort-term risk and long-term incidence rate of herpes zoster with upadacitinib in patients with atopic dermatitis and psoriatic arthritis: a systematic review and meta-analysis.Postepy dermatologii i alergologii
Observational studyChanges in biventricular myocardial function after six months of ixekizumab therapy in patients with psoriatic arthritis: a prospective speckle-tracking echocardiographic study.Rheumatology international
Depressive symptoms are associated with achieving remission in PsA patients - an analysis from the RABBIT-SpA register.BMC rheumatology